HARNESS THE POWER OF EARLY PHASE DEVELOPMENT SOLUTIONS

Earn valuable continuity credits that save you moneyAt each phase, earn up to 10% credit towards the next phase ...

Go faster from lead candidate to proof of concept.

Get a focused team for the duration of your program

10%credit

With the potential

to save as much as...

$500,000

Realize up to 30% time savings with our Programmatic Model

Dedicated Drug Development Leader

Supported by Certified Project Manager

Backed by 4,800+ drugdevelopment experts

worldwide

Transactional Approach

Programmatic Model

Transactional Approach

Programmatic Model

FIHFirst InHumans

INDInvestigational

New Drug

POCProof OfConcept

10%credit

Source: Internal metrics 2012 – 2016

2 out of 3biotechs who consider the

Programmatic Model adopt it

Estimate your potential value via a complimentary assessment from our Economic Valuator™

Estimate NPV, runway, direct/indirect FTE cost

Start saving today.Visit www.covance.com/epds

Move your molecule through its developmentphases efficiently with proven projectmanagement and ongoing communications

More biotechs choose Covance confidently

65+ NEW IND/CTApackages initiated each year

125+ clientsutilize the programmatic

approach annually

BudgetTracker

RiskAssessment

Regular Calls

StatusReports

Covance Inc., headquartered in Princeton, NJ, USA, is the drug development business of Laboratory Corporation of America Holdings (LabCorp). COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.

The Americas + 1.888.COVANCE (+1.888.268.2623) + 1.609.452.4440

Europe / Africa + 00.800.2682.2682 +44.1423.500888

Asia Pacific + 800.6568.3000 +65.6.5686588

© Copyright 2017 Covance Inc. INFCVD004-0917